Evidence map›Paper›PMID 34020708›Full record

ArticleGenome medicine2021

Genotype-phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders.

Ilaria Mannucci, Nghi D P Dang, Hannes Huber, Jaclyn B Murry, Jeff Abramson, Thorsten Althoff, Siddharth Banka, Gareth Baynam, David Bearden, Ana Beleza-Meireles and 55 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Engineering precision zebrafish alleles of human disease.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Profile ofFrontiers in endocrinology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

65 authors at 20 institutions in 8 countries.

Ilaria MannucciInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Nghi D P DangDepartment of Pharmacology and Toxicology, University of Alabama, Birmingham, USA.
Hannes HuberDepartment of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, 97070, Würzburg, Germany.
Jaclyn B MurryDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Jeff AbramsonDepartment of Physiology, University of California Los Angeles, Los Angeles, CA, USA.
Thorsten AlthoffDepartment of Physiology, University of California Los Angeles, Los Angeles, CA, USA.
Siddharth BankaManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Gareth BaynamFaculty of Medicine and Health Sciences, University of Western Australia, Perth, WA, Australia.
David BeardenDivision of Child Neurology, Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA.
Ana Beleza-MeirelesClinical Genetics Department, University Hospitals Bristol and Weston, Bristol, UK.
Paul J BenkeJoe DiMaggio Children's Hospital, Hollywood, FL, USA.
Siren BerlandDepartment of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.
Tatjana BierhalsInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Frederic BilanDepartment of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
Laurence A BindoffDepartment of Clinical Medicine (K1), University of Bergen, Bergen, Norway.
Geir Julius BraathenDepartment of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
Øyvind L BuskDepartment of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
Jirat ChenbhanichDivision of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Jonas DeneckeDepartment of Pediatrics, University Medical Center Eppendorf, 20246, Hamburg, Germany.
Luis F EscobarPeyton Manning Children's Hospital, Ascension Health, Indianapolis, IN, USA.
Caroline EstesPeyton Manning Children's Hospital, Ascension Health, Indianapolis, IN, USA.
Julie FleischerDepartment of Pediatrics, Southern Illinois University School of Medicine, Springfield, IL, 62702, USA.
Daniel GroepperDepartment of Pediatrics, Southern Illinois University School of Medicine, Springfield, IL, 62702, USA.
Charlotte A HaaxmaDepartment of Pediatric Neurology, Amalia Children's Hospital and Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Maja HempelInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Yolanda Holler-ManaganDivision of Neurology, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Gunnar HougeDepartment of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.
Adam JacksonManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Laura KelloggKaiser Permanente Sacramento, Sacramento, USA.
Boris KerenDépartement de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Catherine Kiraly-BorriGenetic Services of Western Australia, Perth, Western Australia, 6008, Australia.
Cornelia KrausInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
Christian KubischInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Gwenael Le GuyaderDepartment of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
Ulf W LjungbladDepartment of Pediatrics, Vestfold Hospital, 3116, Tønsberg, Norway.
Leslie Manace BrenmanDepartment of Genetics, Kaiser Permanente Northern California, Oakland, USA.
Julian A Martinez-AgostoUCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
Matthew MightDepartment of Medicine, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 510 20th St S, Birmingham, AL, 35210, USA.
David T MillerDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
Kelly Q MinksDivision of Child Neurology, Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA.
Billur MoghaddamKaiser Permanente Sacramento, Sacramento, USA.
Caroline NavaDépartement de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Stanley F NelsonUCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
John M ParantDepartment of Pharmacology and Toxicology, University of Alabama, Birmingham, USA.
Trine PrescottDepartment of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
Farrah RajabiDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
Hanitra RandrianaivoUF de Génétique Médicale, GHSR, CHU de La Réunion, Saint Pierre, La Réunion, France.
Simone F ReiterDepartment of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.
Janneke Schuurs-HoeijmakersDepartment of Human Genetics, Radboud University Medical Center, 6500 HB, Nijmegen, the Netherlands.
Perry B ShiehDepartment of Neurology at David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Anne SlavotinekDivision of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Sarah SmithsonClinical Genetics Department, University Hospitals Bristol and Weston, Bristol, UK.
Alexander P A StegmannDepartment of Human Genetics, Radboud University Medical Center, 6500 HB, Nijmegen, the Netherlands.
Kinga TomczakDepartment of Neurology, Boston Children's Hospital, Boston, MA, USA.
Kristian TvetenDepartment of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
Jun WangDepartment of Pharmacology and Toxicology, University of Alabama, Birmingham, USA.
Jordan H WhitlockDepartment of Medicine, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 510 20th St S, Birmingham, AL, 35210, USA.
Christiane ZweierInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
Kirsty McWalterGeneDx, Gaithersburg, MD, 20877, USA.
Jane JuusolaGeneDx, Gaithersburg, MD, 20877, USA.
Fabiola Quintero-RiveraDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Utz FischerDepartment of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, 97070, Würzburg, Germany.
Nan Cher YeoDepartment of Pharmacology and Toxicology, University of Alabama, Birmingham, USA. nyeo@uab.edu.
Hans-Jürgen KreienkampInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany. kreienkamp@uke.de.
Davor LesselInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany. d.lessel@uke.de.ORCID 0000-0003-4496-244X
Universität Hamburg · DEUniversity of California, Los Angeles · USUniversity of Alabama at Birmingham · USHaukeland University Hospital · NOTelemark Hospital · NOBoston Children's Hospital · USRadboud University Nijmegen · NLAscension · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DEInserm · FRKaiser Permanente Sacramento Medical Center · USSorbonne Université · FRSouthern Illinois University School of Medicine · USUniversity Hospitals Bristol NHS Foundation Trust · GBUniversity of California, San Francisco · USUniversity of Manchester · GBUniversity of Rochester · USUniversity of Würzburg · DEJoe DiMaggio Children's Hospital · USKaiser Permanente · US

Funding

UAB Pilot Center for Precision Animal Modeling (C-PAM) - Resource and Service SectionU54OD030167 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Bradley K. Yoder · 2020 to 2026
$15.3M
Deciphering molecular details of cellular sugar transport and their roles in diseaseR35GM135175 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ABRAMSON, JEFFREY S · 2020 to 2024
$3.9M
Longitudinal Cognitive Outcomes in Children and Adolescents with HIV in ZambiaK23NS117310 · NINDS · UNIVERSITY OF ROCHESTER · PI BEARDEN, DAVID ROSS · 2020 to 2024
$1.0M
NIGMS NIH HHS R35 GM135175NIH HHS U54 OD030167NINDS NIH HHS K23 NS117310
6 · The paper itself

Abstract

backgroundWe aimed to define the clinical and variant spectrum and to provide novel molecular insights into the DHX30-associated neurodevelopmental disorder.

methodsClinical and genetic data from affected individuals were collected through Facebook-based family support group, GeneMatcher, and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30-deficient HEK293T and zebrafish models, along with in vivo behavioral assays.

resultsWe identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment, and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual harboring a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location, and type we establish two distinct clinical subtypes. DHX30 loss-of-function variants cause a milder phenotype whereas a severe phenotype is caused by HCM missense variants that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of-function with respect to SG formation. Behavioral characterization of dhx30-deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype.

conclusionsOur study highlights the usefulness of social media to define novel Mendelian disorders and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories, and research laboratories.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAnimalsBiomarkersGene ExpressionGene Knockdown TechniquesGerm-Line MutationHEK293 CellsHumansImmunohistochemistryMutationNeurodevelopmental DisordersPhenotypeRNA HelicasesZebrafishBiomarkersDHX30 protein, humanRNA Helicases

Identifiers

PMID34020708
PMCPMC8140440
OpenAlexW3160712508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.